247 related articles for article (PubMed ID: 27431395)
1. Clinical outcomes of deferred revascularisation using fractional flow reserve in patients with and without diabetes mellitus.
Kennedy MW; Kaplan E; Hermanides RS; Fabris E; Hemradj V; Koopmans PC; Dambrink JH; Marcel Gosselink AT; Van't Hof AW; Ottervanger JP; Roolvink V; Remkes WS; van der Sluis A; Suryapranata H; Kedhi E
Cardiovasc Diabetol; 2016 Jul; 15():100. PubMed ID: 27431395
[TBL] [Abstract][Full Text] [Related]
2. Fractional Flow Reserve-Guided Deferred Versus Complete Revascularization in Patients With Diabetes Mellitus.
Kennedy MW; Hermanides RS; Kaplan E; Hemradj V; Fabris E; Koopmans PC; Dambrink JE; Gosselink AT; Van't Hof AW; Ottervanger JP; Roolvink V; Remkes WS; van der Sluis A; Suryapranata H; Kedhi E
Am J Cardiol; 2016 Nov; 118(9):1293-1299. PubMed ID: 27614852
[TBL] [Abstract][Full Text] [Related]
3. Outcome of coronary lesions with deferred revascularization due to negative fractional flow reserve in subjects with acute coronary syndrome.
Picchi A; Leone AM; Zilio F; Cerrato E; D'Ascenzo F; Fineschi M; Rigattieri S; Ferlini M; Cameli M; Calabria P; Cresti A; Limbruno U
Int J Cardiol; 2017 Mar; 230():335-338. PubMed ID: 28040284
[TBL] [Abstract][Full Text] [Related]
4. Relation between fractional flow reserve value of coronary lesions with deferred revascularization and cardiovascular outcomes in non-diabetic and diabetic patients.
Liu Z; Matsuzawa Y; Herrmann J; Li J; Lennon RJ; Crusan DJ; Kwon TG; Zhang M; Sun T; Yang S; Gulati R; Bell MR; Lerman LO; Lerman A
Int J Cardiol; 2016 Sep; 219():56-62. PubMed ID: 27281577
[TBL] [Abstract][Full Text] [Related]
5. Clinical Outcomes of Deferred Revascularisation Using Fractional Flow Reserve in Diabetic Patients.
Alkhalil M; McCune C; McClenaghan L; Mailey J; Collins P; Kearney A; Todd M; McKavanagh P
Cardiovasc Revasc Med; 2020 Jul; 21(7):897-902. PubMed ID: 31883978
[TBL] [Abstract][Full Text] [Related]
6. Factors associated with deferred lesion failure following fractional flow reserve assessment in patients with diabetes mellitus.
Kennedy MW; Fabris E; Hermanides RS; Kaplan E; Borren N; Berta B; Koopmans PC; Ottervanger JP; Suryapranata H; Kedhi E
Catheter Cardiovasc Interv; 2017 Dec; 90(7):1077-1083. PubMed ID: 28303683
[TBL] [Abstract][Full Text] [Related]
7. Clinical Outcomes in Patients with Deferred Coronary Lesions according to Disease Severity Assessed by Fractional Flow Reserve.
Won KB; Nam CW; Cho YK; Yoon HJ; Park HS; Kim H; Han S; Hur SH; Kim YN; Park SH; Han JK; Koo BK; Kim HS; Doh JH; Lee SY; Yang HM; Lim HS; Yoon MH; Tahk SJ; Kim KB
J Korean Med Sci; 2016 Dec; 31(12):1929-1936. PubMed ID: 27822931
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of coronary stenoses deferred revascularization for borderline versus nonborderline fractional flow reserve values.
Depta JP; Patel JS; Novak E; Masrani SK; Raymer D; Facey G; Patel Y; Zajarias A; Lasala JM; Singh J; Bach RG; Kurz HI
Am J Cardiol; 2014 Jun; 113(11):1788-93. PubMed ID: 24837255
[TBL] [Abstract][Full Text] [Related]
9. [FFR-Guided Revascularisation - Pros and Cons].
Reuter H; Baldus S
Dtsch Med Wochenschr; 2017 Oct; 142(21):1595-1603. PubMed ID: 29046003
[TBL] [Abstract][Full Text] [Related]
10. Association of Lower Fractional Flow Reserve Values With Higher Risk of Adverse Cardiac Events for Lesions Deferred Revascularization Among Patients With Acute Coronary Syndrome.
Masrani Mehta S; Depta JP; Novak E; Patel JS; Patel Y; Raymer D; Facey G; Zajarias A; Lasala JM; Singh J; Bach RG; Kurz HI
J Am Heart Assoc; 2015 Aug; 4(8):e002172. PubMed ID: 26289346
[TBL] [Abstract][Full Text] [Related]
11. Combined optical coherence tomography morphologic and fractional flow reserve hemodynamic assessment of non- culprit lesions to better predict adverse event outcomes in diabetes mellitus patients: COMBINE (OCT-FFR) prospective study. Rationale and design.
Kennedy MW; Fabris E; Ijsselmuiden AJ; Nef H; Reith S; Escaned J; Alfonso F; van Royen N; Wojakowski W; Witkowski A; Indolfi C; Ottervanger JP; Suryapranata H; Kedhi E
Cardiovasc Diabetol; 2016 Oct; 15(1):144. PubMed ID: 27724869
[TBL] [Abstract][Full Text] [Related]
12. Long-Term Patient-Related and Lesion-Related Outcomes After Real-World Fractional Flow Reserve Use.
Doh JH; Nam CW; Koo BK; Park SH; Lee JH; Han JK; Yang HM; Lim HS; Yoon MH; Cho YK; Hur SH; Lee SY; Kim HS; Tahk SJ
J Invasive Cardiol; 2015 Sep; 27(9):410-5. PubMed ID: 26332875
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of deferred revascularisation following negative fractional flow reserve in diabetic and non-diabetic patients: a meta-analysis.
Ekmejian A; Sritharan H; Selvakumar D; Venkateshka V; Allahwala U; Ward M; Bhindi R
Cardiovasc Diabetol; 2023 Jan; 22(1):22. PubMed ID: 36717847
[TBL] [Abstract][Full Text] [Related]
14. Vessel-Specific Outcomes of Deferred Revascularization Following Negative Fractional Flow Reserve.
Ekmejian A; Brieger D; Bhat A; Sritharan H; Nour D; Allahwala U; Ward M; Bhindi R
Am J Cardiol; 2023 Aug; 201():320-327. PubMed ID: 37399598
[TBL] [Abstract][Full Text] [Related]
15. Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trial.
Engstrøm T; Kelbæk H; Helqvist S; Høfsten DE; Kløvgaard L; Holmvang L; Jørgensen E; Pedersen F; Saunamäki K; Clemmensen P; De Backer O; Ravkilde J; Tilsted HH; Villadsen AB; Aarøe J; Jensen SE; Raungaard B; Køber L;
Lancet; 2015 Aug; 386(9994):665-71. PubMed ID: 26347918
[TBL] [Abstract][Full Text] [Related]
16. Risk model for estimating the 1-year risk of deferred lesion intervention following deferred revascularization after fractional flow reserve assessment.
Depta JP; Patel JS; Novak E; Gage BF; Masrani SK; Raymer D; Facey G; Patel Y; Zajarias A; Lasala JM; Amin AP; Kurz HI; Singh J; Bach RG
Eur Heart J; 2015 Feb; 36(8):509-15. PubMed ID: 25336221
[TBL] [Abstract][Full Text] [Related]
17. The impact of age on fractional flow reserve-guided percutaneous coronary intervention: a FAME (Fractional Flow Reserve versus Angiography for Multivessel Evaluation) trial substudy.
Lim HS; Tonino PA; De Bruyne B; Yong AS; Lee BK; Pijls NH; Fearon WF
Int J Cardiol; 2014 Nov; 177(1):66-70. PubMed ID: 25499342
[TBL] [Abstract][Full Text] [Related]
18. Fractional Flow Reserve Versus Angiographically-Guided Coronary Artery Bypass Grafting.
Thuesen AL; Riber LP; Veien KT; Christiansen EH; Jensen SE; Modrau I; Andreasen JJ; Junker A; Mortensen PE; Jensen LO
J Am Coll Cardiol; 2018 Dec; 72(22):2732-2743. PubMed ID: 30497559
[TBL] [Abstract][Full Text] [Related]
19. Clinical Outcomes of Deferred Lesions by IVUS Versus FFR-Guided Treatment Decision.
Lee JM; Kim H; Hong D; Hwang D; Zhang J; Hu X; Jiang J; Nam CW; Doh JH; Lee BK; Kim W; Huang J; Jiang F; Zhou H; Chen P; Tang L; Jiang W; Chen X; He W; Kang J; Ahn SG; Yoon MH; Kim U; Ki YJ; Shin ES; Choi KH; Park TK; Yang JH; Song YB; Choi SH; Gwon HC; Koo BK; Kim HS; Tahk SJ; Wang J; Hahn JY;
Circ Cardiovasc Interv; 2023 Dec; 16(12):e013308. PubMed ID: 38018840
[TBL] [Abstract][Full Text] [Related]
20. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2-year follow-up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) study.
Pijls NH; Fearon WF; Tonino PA; Siebert U; Ikeno F; Bornschein B; van't Veer M; Klauss V; Manoharan G; Engstrøm T; Oldroyd KG; Ver Lee PN; MacCarthy PA; De Bruyne B;
J Am Coll Cardiol; 2010 Jul; 56(3):177-84. PubMed ID: 20537493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
